Source comparison
Kisspeptin vs Kisspeptin-10: Structure & Function Differences
The confusion around what's the difference between kisspeptin and kisspeptin-10 starts with nomenclature. Kisspeptin-54 is the full-length 54-amino-acid peptide encoded by the KISS1 gene, while kisspeptin-10 is the C-terminal decapeptide fragment that retains
This comparison does not assign a generated winner or score.
- The confusion around what's the difference between kisspeptin and kisspeptin-10 starts with nomenclature. Kisspeptin-54 is the full-length 54-amino-acid peptide encoded by the KISS1 gene, while kisspeptin-10 is the C-terminal decapeptide fragment that retains full biological activity at the GnRH neuron receptor. Both activate KISS1R (GPR54), both trigger luteinising hormone release, both regulate reproductive function. The functional difference isn't whether they work. It's how they're metabolised, how they're dosed, and which form matches your experimental endpoint. A 2018 study published in Frontiers in Endocrinology found that kisspeptin-10 reaches peak plasma concentration 40–50% faster than kisspeptin-54 after subcutaneous administration, but clears from circulation within 30–45 minutes compared to 90–120 minutes for the full-length peptide.
- Our team works directly with researchers designing reproductive endocrinology protocols. The gap between picking the wrong isoform and getting usable data comes down to three things: receptor kinetics, proteolytic stability, and dosing intervals that match your sampling window.
- What's the difference between kisspeptin and kisspeptin-10?
- Kisspeptin-10 is the 10-amino-acid C-terminal fragment (amino acids 45–54) of full-length kisspeptin-54. Both activate the KISS1R receptor on GnRH neurons with identical affinity, but kisspeptin-10 is more resistant to N-terminal proteolytic degradation and reaches peak plasma concentration approximately 40% faster after injection. The functional output. GnRH release and subsequent LH/FSH pulsatility. Is indistinguishable between the two peptides at equivalent molar doses, but kisspeptin-10's shorter half-life makes it preferable for acute-response studies where timing precision matters.